CNBX Pharmaceuticals Inc. (CNBX)
USD 0.01
(42.86%)
USD 0.01
(42.86%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 410.16 Thousand | 29.95 Thousand | - | 7157.00 | 9843.00 | 9601.00 |
| Cost of Revenue | - | 198.52 Thousand | 220.92 Thousand | - | - | 1.00 |
| Gross Profit | 410.16 Thousand | -168.56 Thousand | -220.92 Thousand | 7157.00 | 9843.00 | 9600.00 |
| Operating Expenses | 1.34 Million | 2.95 Million | 2.6 Million | 3.05 Million | 3.31 Million | 3.81 Million |
| Selling, General and Administrative Expenses | 909.98 Thousand | 1.77 Million | 828.64 Thousand | 1.36 Million | 1.76 Million | 2.81 Million |
| Research and Development Expenses | 431.56 Thousand | 1.18 Million | 1.77 Million | 1.68 Million | 1.54 Million | 1 Million |
| Other Expenses | - | -722.23 Thousand | -706.86 Thousand | -4.36 Million | 19.62 Thousand | -4.00 |
| Cost and Expenses | 1.34 Million | 2.95 Million | 2.6 Million | 3.05 Million | 3.31 Million | 3.81 Million |
| Operating Income | -931.38 Thousand | -2.95 Million | -2.6 Million | -3.04 Million | -3.3 Million | -3.8 Million |
| Interest Expense | 1174.00 | 1273.00 | 2391.00 | 8133.00 | 18.34 Thousand | 852.00 |
| Income Tax Expense | - | 45.77 Thousand | -704.47 Thousand | -4.35 Million | 37.96 Thousand | 32.96 Thousand |
| Earnings before Tax | -3.71 Million | -3.72 Million | -3.19 Million | -7.46 Million | 1.13 Million | -3.77 Million |
| Net Income | -3.71 Million | -3.76 Million | -2.48 Million | -3.11 Million | 1.13 Million | -3.77 Million |
| Earnings Per Share Basic | -0.42 | -3.08 | -2.16 | -2.78 | 1.03 | -3.76 |
| Earnings Per Share Diluted | -0.42 | -3.08 | -2.16 | -2.78 | 1.03 | -3.76 |
| Weighted Average Shares Outstanding | 8.82 Million | 1.22 Million | 1.15 Million | 1.12 Million | 1.1 Million | 1 Million |
| Weighted Average Shares Outstanding (Diluted) | 8.82 Million | 1.22 Million | 1.15 Million | 1.12 Million | 1.1 Million | 1 Million |
| Gross Margin | 1.00 | -5.63 | - | 1.00 | 1.00 | 1.00 |
| EBIT Margin | -8.65 | -116.09 | - | -1013.18 | -314.44 | -390.83 |
| Profit Margin | -9.05 | -125.81 | - | -434.90 | 115.10 | -393.36 |
| EBITDA | -3.54 Million | -3.52 Million | -3.14 Million | -7.24 Million | 1.34 Million | -3.72 Million |
| Earnings Before Tax Margin | -2.27 | -98.60 | - | -425.24 | -335.63 | -396.70 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 310.16 Thousand | 40.63 Thousand | 89.43 Thousand | 100 Thousand | 410.16 Thousand | 310.16 Thousand |
| Cost of Revenue | 292.59 Thousand | 39.07 Thousand | 39.46 Thousand | 38.49 Thousand | 162.06 Thousand | 39.99 Thousand |
| Gross Profit | 17.57 Thousand | 1558.00 | 49.97 Thousand | 61.5 Thousand | 248.1 Thousand | 270.17 Thousand |
| Operating Expenses | 152.27 Thousand | 207.98 Thousand | 261.33 Thousand | 261.49 Thousand | 1.34 Million | 483.24 Thousand |
| Selling, General and Administrative Expenses | 109.39 Thousand | 100.78 Thousand | 148.91 Thousand | 168.26 Thousand | - | 220.13 Thousand |
| Research and Development Expenses | 42.88 Thousand | 107.19 Thousand | 112.41 Thousand | 93.23 Thousand | - | 263.11 Thousand |
| Other Expenses | - | - | - | - | -54.81 Thousand | - |
| Cost and Expenses | 152.27 Thousand | 247.06 Thousand | 261.33 Thousand | 261.49 Thousand | 1.34 Million | 483.24 Thousand |
| Operating Income | -152.28 Thousand | -206.43 Thousand | -171.9 Thousand | -161.49 Thousand | -931.38 Thousand | -173.08 Thousand |
| Interest Expense | - | - | 6623.00 | -4.76 Million | 1174.00 | -18.39 Thousand |
| Income Tax Expense | - | 1.00 | -3815.00 | -4.76 Million | -53.63 Thousand | -18.39 Thousand |
| Earnings before Tax | -130.63 Thousand | -325.45 Thousand | -178.52 Thousand | -516.55 Thousand | -3.71 Million | -191.47 Thousand |
| Net Income | -130.63 Thousand | -325.45 Thousand | -178.52 Thousand | -573.55 Thousand | -3.71 Million | -173.08 Thousand |
| Earnings Per Share Basic | -0.00 | -0.01 | -0.01 | -0.03 | - | -0.02 |
| Earnings Per Share Diluted | -0.00 | -0.01 | -0.01 | -0.03 | - | -0.02 |
| Weighted Average Shares Outstanding | 31.11 Million | 30.98 Million | 27.76 Million | 22.61 Million | 8.82 Million | 9.26 Million |
| Weighted Average Shares Outstanding (Diluted) | 31.11 Million | 30.98 Million | 27.76 Million | 22.61 Million | 8.82 Million | 9.26 Million |
| Gross Margin | 0.06 | 0.04 | 0.56 | 0.62 | 0.60 | 0.87 |
| EBIT Margin | -0.49 | -4.27 | -1.48 | -25.73 | - | -0.43 |
| Profit Margin | -0.42 | -8.01 | -2.00 | -5.74 | -9.05 | -0.56 |
| EBITDA | -152.28 Thousand | -173.57 Thousand | -132.43 Thousand | -2.57 Million | - | -133.08 Thousand |
| Earnings Before Tax Margin | -0.49 | -5.08 | -1.92 | -1.61 | -2.27 | -0.56 |
WLAB
0I0H
328130
603708
JQ
5292